Zobrazeno 1 - 10
of 257
pro vyhledávání: '"V G, Morozov"'
Autor:
T. K. Dzagurova, R. T. Murzabaeva, F. G. Kutluguzhina, V. G. Morozov, E. V. Volnyh, S. S. Kurashova, M. V. Balovneva, P. E. Tkachenko, A. A. Ishmukhametov, A. V. Belyakova, E. A. Tkachenko
Publikováno v:
Инфекция и иммунитет, Vol 12, Iss 3, Pp 527-534 (2022)
Relevance. Hemorrhagic fever with renal syndrome (HFRS) is an acute viral zoonosis. Being widespread in Eurasia, it holds a leading place in Russia among natural focal human diseases. The vast majority of HFRS cases in Russia, about 98%, are associat
Externí odkaz:
https://doaj.org/article/3fb94f27c0fc48298d11a85550ec3bb2
Autor:
T. K. Dzagurova, A. A. Ishmukhametov, V. A. Bakhtina, V. G. Morozov, M. V. Balovneva, S. S. Kurashova, B. .. Klempa, D. .. Kruger, E. A. Tkachenko
Publikováno v:
Вопросы вирусологии, Vol 64, Iss 1, Pp 36-41 (2019)
Introduction. Hemorrhagic fever with renal syndrome (HFRS) occupies a leading place among natural focal human diseases in the Russian Federation. Sporadic incidence of HFRS-Sochi has been annually recorded in the Krasnodar Territory since 2000. The g
Externí odkaz:
https://doaj.org/article/3d8f97163ebf49e1b69b71f1403717d4
Publikováno v:
Radiology - Practice. :50-62
The aim of this work is to evaluate diagnostic value of liver non-contrast perfusion in prediction of visceropathies (sialadenitis and hepatic encephalopathy) in patients with diffuse liver diseases (DLD). Clinical and laboratory data (including the
Autor:
M. V. Maevskaya, E. N. Bessonova, N. I. Geyvandova, E. A. Kitsenko, N. V. Korochanskaia, V. G. Morozov, Y. V. Khoronko
Publikováno v:
Meditsinskiy sovet = Medical Council. :142-147
Seven of the country’s leading experts in the field of therapeutic and surgical hepatology answer questions on this issue: how relevant is thrombocytopenia in patients with CLD for clinical practice, what is the average proportion of patients who n
Autor:
V. V. Ignatyuk, V. G. Morozov
Publikováno v:
Condensed Matter Physics, Vol 25, Iss 1, p 13302 (2022)
The non-Markovian master equation for open quantum systems is obtained by generalization of the standard Zwanzig-Nakajima (ZN) projection technique. To this end, a coupled chain of equations is written for the reduced density matrices of the bath ϱ(
Externí odkaz:
https://doaj.org/article/c3811c72beaf46a49843571fd57dc821
Autor:
M. V. Maevskaya, M. S. Zharkova, V. T. Ivashkin, E. N. Bessonova, N. I. Geyvandova, E. A. Kitsenko, N. V. Korochanskaya, I. A. Kurkina, A. L. Melikyan, V. G. Morozov, Yu. V. Khoronko
Publikováno v:
Meditsinskiy sovet = Medical Council. :70-82
Hemostasis disorders in cirrhosis / severe liver disease are complex, as they affect both pro- and anticoagulant factors, as well as pro- and antifibrinolytic components. Most of the tests that are used in clinical practice to assess coagulation do n
Autor:
I. G. Bakulin, N. A. Bokhan, P. O. Bogomolov, N. I. Geyvandova, M. V. Matsiyevich, M. A. Vinnikova, V. G. Morozov, O. M. Khromtsova, G. S. Soldatova, O. Yu. Shiryayev, R. D. Ilyuk, K. V. Rybakova, A. G. Katkovskaya, S. V. Teplykh, A. A. Bagretsova, M. V. Krasnova, Ye. V. Alekseyeva, A. V. Anipchenko, Ye. V. Baskakov
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 27, Iss 3, Pp 57-68 (2018)
Material and methods. The original study included overall 120 patients with ALD, who were randomized in two identical groups. The patients of the main group (group A) received 2 courses of therapy: the first - Phosphogliv 5 mg/day as intravenous bolu
Externí odkaz:
https://doaj.org/article/4f495eb6776240bda9501c18da8c6da0
Pegilated interferon alpha 2b «Pegaltevir» chronic hepatitis C treatment (randomized clinical trial)
Autor:
Marina V. Mayevskaya, Ye. N. Bessonova, P. O. Bogomolov, N. I. Geyvandova, K. V. Zhdanov, V. G. Morozov, V. D. Pasechnikov, I. Yu. Khomenko, A. V. Yagoda, V. T. Ivashkin
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 26, Iss 6, Pp 69-83 (2018)
Externí odkaz:
https://doaj.org/article/14e4f35f52b640b1807d773161107b05
Autor:
V. T. Ivashkin, M. V. Mayevskaya, D. T. Abdurakhmanov, I. G. Bakulin, N. I. Geyvandova, M. L. Zubkin, S. N. Kizhlo, A. V. Kuznetsova, I. B. Latysheva, N. A. Mamonova, V. G. Morozov, O. I. Sagalova, Ye. V. Esaulenko, Ye. O. Lyusina
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 27, Iss 6, Pp 52-62 (2018)
Externí odkaz:
https://doaj.org/article/648fb9a0265848459515bd7b7ee40f58
Autor:
M. V. Mayevskaya, V. T. Ivashkin, O. O. Znoyko, Ye. A. Klimova, D. T. Abdurakhmanov, I. G. Bakulin, P. O. Bogomolov, E. Z. Burnevich, M. Yu. Galushko, N. I. Geyvandova, K. V. Zhdanov, Ye. V. Esaulenko, S. N. Kizhlo, D. Yu. Konstantinov, N. I. Mironova, V. G. Morozov, Ye. A. Strebkova, I. G. Nikitin, M. F. Osipenko, V. D. Pasechnikov, O. I. Sagalova, I. M. Khayertynova, V. P. Chulanov, A. A. Yakovlev, I. A. Vasyutin, Ye. P. Tarkhova, E. N. Krasavina, M. Yu. Samsonov
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 27, Iss 6, Pp 41-51 (2018)
Aim of investigation. To estimate efficacy and safety of narlaprevir (NVR) with ritonavir (RTV), pegilated interferon (peg-IFN) and ribavirin (RBV) at treatmentnaïve and earlier treated noncirrhotic patients with chronic hepatitis C caused by the 1s
Externí odkaz:
https://doaj.org/article/0686acb179664d0d893a6a2414c4957c